Enlivex Ltd. Faces Nasdaq Delisting Notice
The company failed to maintain a $1.00 minimum bid price, forcing an appeal to stay off the exchange.
Updated on Oct. 27, 2026 in Public Companies
Live Poll
Does receiving a delisting notice from a major stock exchange change your trust in a company?
The Nasdaq Stock Market issued a delisting notice to Enlivex Ltd. after the company failed to maintain the $1.00 minimum bid price requirement for 30 consecutive business days. Enlivex has initiated a challenge to the decision, which automatically stays any immediate delisting actions.
Why it matters
The notice highlights the persistent difficulty public companies face in maintaining minimum share price thresholds, particularly when previous corrective measures like reverse splits have already been exhausted. For operators, this serves as a reminder of the strict compliance standards required to retain major exchange listings.
Nasdaq issued a delisting notice to Enlivex Ltd. after its stock failed to meet the $1.00 minimum bid price for 30 consecutive business days. The company recently implemented a 1-for-16 reverse share split on October 27, 2026, to address market valuation concerns.
The players
Enlivex Ltd.
An Israel-based biopharmaceutical company focused on the development of immunotherapy treatments.
Nasdaq Stock Market
A global electronic exchange that enforces listing standards and capital requirements for publicly traded companies.
The details
Nasdaq mandates a minimum $1.00 closing bid price for all listed entities. Because Enlivex implemented a 1-for-16 reverse share split within the preceding 12 months, the company is ineligible for the standard 180-day compliance window. Enlivex is now seeking an oral hearing before the Nasdaq Hearings Panel to contest the move, which effectively pauses any suspension or delisting pending the panel's review.
Timeline
October 26, 2026: Nasdaq issues the formal delisting notification.
October 27, 2026: The company implements a 1-for-16 reverse share split.
Market Landscape
The action follows the standard enforcement of Nasdaq's minimum bid price requirement, which aims to keep low-value, high-volatility stocks off the exchange. This case highlights the limited options for companies that have already utilized reverse splits to prop up their share price.
Operators and public firm stakeholders should track the upcoming Nasdaq Hearings Panel appeal, as a failure to reverse the delisting will force the stock to secondary markets. Business leaders should monitor these exchange compliance triggers as early warning signs of broader capital access challenges.
The takeaway
Maintaining exchange compliance is a critical operational hurdle that impacts market liquidity and investor perception. Companies should proactively audit their listing compliance status against exchange rules, particularly regarding the timing and frequency of reverse stock splits.
Further reading
For broader trends affecting market listing standards, explore our Public Companies archives.
Live Poll
Does receiving a delisting notice from a major stock exchange change your trust in a company?
